Evolus, Inc. (EOLS) financial statements and ratios from SEC XBRL: revenue $297.18M (TTM), net margin -17.4%, revenue growth 11.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $297.18M |
| Net Margin | -17.4% |
| Revenue Growth (YoY) | 11.6% |
| EPS Growth (YoY) | -1.2% |
| FCF Growth (YoY) | 134.7% |
| Price / Sales | 1.85 |
| FCF Yield | -16.6% |
| Altman Z-Score | -1.58 (distress) |
| Piotroski F-Score | 2/9 |
| Sector P/E (Healthcare) | 21.7 |
EOLS overview · EOLS earnings · EOLS KPIs · EOLS investor relations · EOLS ownership · EOLS peers · EOLS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.